These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31267865)

  • 81. RFDT: A Rotation Forest-based Predictor for Predicting Drug-Target Interactions Using Drug Structure and Protein Sequence Information.
    Wang L; You ZH; Chen X; Yan X; Liu G; Zhang W
    Curr Protein Pept Sci; 2018; 19(5):445-454. PubMed ID: 27842479
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities.
    Matthews EJ; Ursem CJ; Kruhlak NL; Benz RD; Sabaté DA; Yang C; Klopman G; Contrera JF
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):23-42. PubMed ID: 19422098
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chemical-protein interactome and its application in off-target identification.
    Yang L; Wang KJ; Wang LS; Jegga AG; Qin SY; He G; Chen J; Xiao Y; He L
    Interdiscip Sci; 2011 Mar; 3(1):22-30. PubMed ID: 21369884
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 85. DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks.
    Xiong B; Liu K; Wu J; Burk DL; Jiang H; Shen J
    Bioinformatics; 2008 Sep; 24(18):2117-8. PubMed ID: 18658180
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Drugs in other drugs: a new look at drugs as fragments.
    Siegel MG; Vieth M
    Drug Discov Today; 2007 Jan; 12(1-2):71-9. PubMed ID: 17198975
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Oral adverse effects: drug-induced tongue disorders.
    Aziz Y; Rademacher WMH; Hielema A; Wishaw SBP; van Diermen DE; de Lange J; Vissink A; Rozema FR
    Oral Dis; 2021 Sep; 27(6):1528-1541. PubMed ID: 33052611
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Exploring the relationship between drug side-effects and therapeutic indications.
    Zhang P; Wang F; Hu J; Sorrentino R
    AMIA Annu Symp Proc; 2013; 2013():1568-77. PubMed ID: 24551427
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A comprehensive review of computational techniques for the prediction of drug side effects.
    Sachdev K; Gupta MK
    Drug Dev Res; 2020 Sep; 81(6):650-670. PubMed ID: 32314424
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An Ensemble Approach for Drug Side Effect Prediction.
    Jahid MJ; Ruan J
    Proceedings (IEEE Int Conf Bioinformatics Biomed); 2013; ():440-445. PubMed ID: 25327524
    [No Abstract]   [Full Text] [Related]  

  • 91. Data science-driven analyses of drugs inducing hypertension as an adverse effect.
    Sharma R
    Mol Divers; 2021 May; 25(2):801-810. PubMed ID: 32415493
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.
    O'Hagan S; Kell DB
    Front Pharmacol; 2015; 6():105. PubMed ID: 26029108
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Target essentiality and centrality characterize drug side effects.
    Wang X; Thijssen B; Yu H
    PLoS Comput Biol; 2013; 9(7):e1003119. PubMed ID: 23874169
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Correction to "Discovering Proangiogenic Drugs in Ischemic Stroke Based on the Relationship between Protein Domain and Drug Substructure".
    Li Y; Zhu H; Yang J; Ke K; Zhu Y; Chen L; Qu Y; Suo R; Chen X; Zhu Y
    ACS Chem Neurosci; 2022 Jul; 13(14):2236-2237. PubMed ID: 35802870
    [No Abstract]   [Full Text] [Related]  

  • 95. Asymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System.
    Gardea-Gutiérrez D; Núñez-García E; Oseguera-Guerra BE; Román-Aguirre M; Montes-Fonseca SL
    Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375725
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Relating Substructures and Side Effects of Drugs with Chemical-chemical Interactions.
    Zhou B; Zhao X; Lu J; Sun Z; Liu M; Zhou Y; Liu R; Wang Y
    Comb Chem High Throughput Screen; 2020; 23(4):285-294. PubMed ID: 31267865
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Identification of Nontoxic Substructures: A New Strategy to Avoid Potential Toxicity Risk.
    Yang H; Sun L; Li W; Liu G; Tang Y
    Toxicol Sci; 2018 Oct; 165(2):396-407. PubMed ID: 29893961
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Predicting drug side-effect profiles: a chemical fragment-based approach.
    Pauwels E; Stoven V; Yamanishi Y
    BMC Bioinformatics; 2011 May; 12():169. PubMed ID: 21586169
    [TBL] [Abstract][Full Text] [Related]  

  • 99. STNN-DDI: a Substructure-aware Tensor Neural Network to predict Drug-Drug Interactions.
    Yu H; Zhao S; Shi J
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35667078
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Impact of computational structure-based predictive toxicology in drug discovery.
    Mohan CG
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):417-26. PubMed ID: 21470184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.